NDC00172-2982-60: CHLORDIAZEPOXIDE HYDROCHLORIDE A.
CHLORDIAZEPOXIDE HYDROCHLORIDE A. Key specifications include administration: ORAL, special_features: ACTIVE MEDICAMENT MEDICINAL STRENGTH:5.000 MILLIGRAMS OF CHLORDIAZEPOXIDE ACTIVE INGREDIENTS, primary_container_type: BOTTLE, capsule_primary_container_content_quantity: 100.000. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-284-5150, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| administration | ORAL |
| special_features | ACTIVE MEDICAMENT MEDICINAL STRENGTH:5.000 MILLIGRAMS OF CHLORDIAZEPOXIDE ACTIVE INGREDIENTS |
| primary_container_type | BOTTLE |
| active_medicament_medicinal_strength | 5.000 MILLIGRAMS CHLORDIAZEPOXIDE HYDROCHLORIDE ACTIVE INGREDIENT AND 2.500 MILLIGRAMS CLIDINIUM BROMIDE ACTIVE INGREDIENT |
| capsule_primary_container_content_quantity | 100.000 |
| NSN | 6505-01-284-5150 |
| ADMINISTRATION | ORAL |
| PRIMARY CONTAINER TYPE | BOTTLE |
| SPECIAL FEATURES | ACTIVE MEDICAMENT MEDICINAL STRENGTH:5.000 MILLIGRAMS OF CHLORDIAZEPOXIDE ACTIVE INGREDIENTS |
| CAPSULE PRIMARY CONTAINER CONTENT QUANTITY | 100.000 |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 5.000 MILLIGRAMS CHLORDIAZEPOXIDE HYDROCHLORIDE ACTIVE INGREDIENT AND 2.500 MILLIGRAMS CLIDINIUM BROMIDE ACTIVE INGREDIENT |
No substitute or cross-reference records for this part.